Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B. Johnson, Joseph I. Clark, Donald P. Lawrence et al.|JAMA Oncology|2015Cited by 656
Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in MelanomaXiaoqi Xie, Janice M. Mehnert|PLoS ONE|2013Cited by 151
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumorsElizabeth J. Davis, Janice M. Mehnert, Juan Martín-Liberal et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 93
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced MelanomaOmid Hamid, Giuseppe Gullo, Karl D. Lewis et al.|Journal of Clinical Oncology|2024Cited by 37